November 05, 2025

Get In Touch

Vitamin D Supplementation Beneficial For Glucose Markers Among Postmenopausal Women

The increase in the prevalence of type 2 diabetes is closely linked to the upsurge in obesity. Obesity and associated metabolic syndrome is also linked to impaired glucose tolerance. Epidemiological studies have linked low vitamin D levels to the pathogenesis of diabetes and also supported the favorable effects of adequate vitamin D intake on reducing the risk of T2D.

Dr Hao L et al. and colleagues have recently found in a new study that among postmenopausal women, Vitamin D is beneficial for glucose markers but not obesity.

The findings of the study have been published in the Journal Clinical Therapeutics.
The effect of vitamin D effect on glucose markers and obesity in postmenopausal women remains controversial. There needs to be more data available on the dosage and duration of vitamin D for optimal efficacy in postmenopausal women. This background was researched in the present study using databases without language restrictions. The data was collected from PubMed/MEDLINE, Web of Science, EMBASE, and Scopus.
A total of Nine eligible articles with 12 comparisons qualified for the final quantitative analysis and the findings could be summarised as follows:
An overall decrease was noted in fasting blood glucose, homeostatic model assessment for insulin resistance, insulin and glycosylated haemoglobin with a weighted mean difference of -3.56 mg/dL; -1.168 mm; -2.26 units; and -0.41%, respectively after vitamin D administration in postmenopausal women.
In subgroup analyses, there was a notable decrease in fasting blood glucose when the intervention course was ˃6 months and dosage ≤1000 IU/d with WMD, -3.48 mg/dL.
Vitamin D was not associated with body mass index, weight, or waist circumference.
The researchers have concluded that Vitamin D is beneficial for glucose markers but not obesity in postmenopausal women.
However a personalized dosage plan for vitamin D should be implemented for postmenopausal women based on the target clinical outcomes.
Further reading:
DOI: https://doi.org/10.1016/j.clinthera.2023.07.009

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!